Zilebesiran sodium

Zilebesiran is a siRNA compound that reduces angiotensinogen levels in the liver, and is utilized in hypertension-related research. Angiotensinogen is the primary precursor of angiotensin peptides and a crucial factor in the regulation of systemic blood pressure.